Humulin 70-30 Articles
Roche beaten down on vitamin unit sale price
17 February 2003
Roche expands position in diabetes market
17 February 2003
Novo Nordisk
17 February 2003
Aventis updates on near-term pipeline
10 February 2003
2003 will fall below forecast, says Eli Lilly
10 February 2003
Wockhardt to launch Indian insulin product
10 February 2003
Sankyo to help GSK sell Avandia in Japan
3 February 2003
Finland plans generic substitution in April
27 January 2003
Novo Nordisk 1st half allays fears
12 August 2002
Aventis and Peptor sign diabetes agreement
5 August 2002
Novo Nordisk stops ragaglitazar trials
29 July 2002
Eli Lilly 2nd-qtr sales decrease 9%
29 July 2002
US HMO need not fund Viagra, court rules
8 July 2002
Tokyo pharma stocks - week to June 24
1 July 2002
Exubera superior to oral drugs in diabetes
24 June 2002
Xenical can help in diabetes management
24 June 2002
Avandia may impact heart risk factors
24 June 2002
Medtronic says artificial pancreas close to reality
24 June 2002
Wyeth drops PTP-112
17 June 2002
UK's MDA advises on insulin pen replacement program
17 June 2002
Wyeth drops PTP-112
17 June 2002
Aerogen cuts workforce
17 June 2002
Orthoclone may have role in type 1 diabetes
3 June 2002
Yamanouchi expects YM175 OK this year
3 June 2002
Genentech licenses IGF-1 rights to Tercica
27 May 2002
GSK and Nobex to develop oral insulin products
27 May 2002
Novartis' Starlix aids glucose control
20 May 2002
Exubera effective, but lung function declines
13 May 2002
Novo Nordisk net profit plunges 21%
13 May 2002
Oral insulin from BioSante
6 May 2002
Aventis blockbusters driving growth
6 May 2002
Profit warning at Novo Nordisk
22 April 2002
Aventis unveils major new Lantus trials
22 April 2002
Novo launches new insulin product in EU
1 April 2002
Biovitrum's BVT.3498 in Phase I
18 March 2002
New ECoJ opinion backs parallel importer
18 March 2002
Eli Lilly diabetes conference webcast
18 March 2002
Fujisawa's tacrolimus in Phase III for IBD
11 March 2002
TranXenoGen posts $4 million loss for 2001
11 March 2002
Plaudits for Lilly as employer, Rx discounter
11 March 2002
Tokyo pharma stocks - week to February 18
25 February 2002
Aventis' Exubera to be filed by year-end?
18 February 2002
Pretax profits up 25% at Novo Nordisk
18 February 2002
US patent for Lorus anticancer drugs
18 February 2002
India revises prices of 62 drug formulations
11 February 2002
Transition Thera and Waratah complete merger
4 February 2002
Novo Nordisk terminates Basulin agreement with Flamel.
21 January 2002
Indian drugmakers Dr Reddy's and Ranbaxy expand sales.
21 January 2002
Neurocrine, Taisho start diabetes vaccine study
14 January 2002
India's NPPA revises 81 formulation prices
14 January 2002
Novo's NovoLog receives US approval for use in pumps
7 January 2002
SpectRx acquires Sterling Medivations for $4.4 million
7 January 2002
Amylin to take Symlin back to clinic
7 January 2002
Amylin to take Symlin back to clinic
28 December 2001
Novo Nordisk risks losing Algerian insulin market
30 November 2001
Peptor drug shows promise in diabetes
26 November 2001
DGI delivers insulin mimics to Novo Nordisk
26 November 2001
Pharmacia's Somavert works in acromegaly
26 November 2001
Indian govt pricing moves for 103 drugs
26 November 2001
NicOx reports new data on NO-aspirin drug in insulin resistance
22 November 2001
Novo reports progress with inhaled insulin
20 November 2001
Novo insulin can save lives in IC units
15 November 2001
Stock Commentary - Europe
15 November 2001
BioSante preclinical data for Bio-Air
8 November 2001
Novo Nordisk starts Ph II on DRF-2725
8 November 2001
Aventis growth driven by strong US pharmaceutical sales
6 November 2001
Novartis ends NN622 deal with Novo Nordisk
30 October 2001
Azeri pharma market reviewed by BISNIS
29 October 2001
Eli Lilly adding 5,000 more sales reps
26 October 2001
Bayer unveils new preclinical drug candidates
26 October 2001
Aradigm gets $20 million from Novo
26 October 2001
Amylin must conduct more Symlin studies
15 October 2001
Host of new products revealed in Ono Pharma's R&D pipeline
8 October 2001
New protein delivery system unit set up by Novo Nordisk
8 October 2001
Aerogen settles inhaler lawsuit with Becton Dickinson
4 October 2001
ViroPharma's NDA for Picovir accepted
1 October 2001
Global pulmonary drug delivery market forecasts
24 September 2001
New Ph II trial data for AeroGen's inhaled insulin
19 September 2001
Novo insulin analog launched in USA
19 September 2001
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
